Related Experiment Videos
Metallothionein and the trace minerals
1Biochemical Sciences Division, Rowett Research Institute, Bucksburn, Aberdeen, United Kingdom.
Annual Review of Nutrition
|January 1, 1990
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Low zinc and selenium concentrations in sepsis are associated with oxidative damage and inflammation.
British journal of anaesthesia·2015
Assessment of zinc and copper status in weaned piglets in relation to dietary zinc and copper supply.
Journal of animal physiology and animal nutrition·2007
Basal metabolic rate and thyroid hormones of late-middle-aged and older human subjects: the ZENITH study.
European journal of clinical nutrition·2005
Copper absorption from foods labelled intrinsically and extrinsically with Cu-65 stable isotope.
European journal of clinical nutrition·2004
Metallothionein gene expression in human adipose tissue from lean and obese subjects.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2002
Mechanisms of NAD+ Homeostasis in Aging and Disease.
Annual review of nutrition·2026
Metabolite Damage and Repair in Health and Disease.
Annual review of nutrition·2026
From Food to Function: Cross-Kingdom Transfer and Regulatory Potential of Dietary microRNAs Highlighted by Breast Milk.
Annual review of nutrition·2026
The Influence of Diet on Cancer Progression and Treatment.
Annual review of nutrition·2026
The Potential Physiologic Mechanisms by Which Early-Life Nutrition May Influence Type 2 Diabetes Pathophysiology in Humans.
Annual review of nutrition·2026
The Paradox and Future of GLP-1/GIP Combination Therapies: Efficacy and Mechanisms.
Annual review of nutrition·2026
First evidence of keratinolytic activity in Simplicillium aogashimaense isolated from wool-pellet-amended soil.
Microbial cell factories·2026
Advanced beneficiation of quartz ore for high-purity silica production.
Scientific reports·2026
Erratum: Advancing hypoparathyroidism treatment: FDA approval of Palopegteriparatide as a promising orphan drug: Erratum.
Annals of medicine and surgery (2012)·2026